WITHDRAWN: Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal

Detalles Bibliográficos
Autores principales: LaFleur, Grace E., Azzi, Andrew G., Schimmel, Scott M., Howard, Mitchell S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576911/
https://www.ncbi.nlm.nih.gov/pubmed/36347749
http://dx.doi.org/10.1016/j.sapharm.2022.10.004
_version_ 1784811635247939584
author LaFleur, Grace E.
Azzi, Andrew G.
Schimmel, Scott M.
Howard, Mitchell S.
author_facet LaFleur, Grace E.
Azzi, Andrew G.
Schimmel, Scott M.
Howard, Mitchell S.
author_sort LaFleur, Grace E.
collection PubMed
description This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal
format Online
Article
Text
id pubmed-9576911
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95769112022-10-18 WITHDRAWN: Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies LaFleur, Grace E. Azzi, Andrew G. Schimmel, Scott M. Howard, Mitchell S. Res Social Adm Pharm Article This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal Elsevier 2022-10-18 /pmc/articles/PMC9576911/ /pubmed/36347749 http://dx.doi.org/10.1016/j.sapharm.2022.10.004 Text en . Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
LaFleur, Grace E.
Azzi, Andrew G.
Schimmel, Scott M.
Howard, Mitchell S.
WITHDRAWN: Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies
title WITHDRAWN: Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies
title_full WITHDRAWN: Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies
title_fullStr WITHDRAWN: Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies
title_full_unstemmed WITHDRAWN: Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies
title_short WITHDRAWN: Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies
title_sort withdrawn: technology targeting immunocompromised patients for covid-19 vaccine in community pharmacies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576911/
https://www.ncbi.nlm.nih.gov/pubmed/36347749
http://dx.doi.org/10.1016/j.sapharm.2022.10.004
work_keys_str_mv AT lafleurgracee withdrawntechnologytargetingimmunocompromisedpatientsforcovid19vaccineincommunitypharmacies
AT azziandrewg withdrawntechnologytargetingimmunocompromisedpatientsforcovid19vaccineincommunitypharmacies
AT schimmelscottm withdrawntechnologytargetingimmunocompromisedpatientsforcovid19vaccineincommunitypharmacies
AT howardmitchells withdrawntechnologytargetingimmunocompromisedpatientsforcovid19vaccineincommunitypharmacies

Ejemplares similares